edaravone has been researched along with Anoxia, Brain in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, reduces brain edema in patients with acute ischemic stroke." | 3.74 | Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia. ( Imaizumi, T; Ishikawa, A; Matsumiya, T; Metoki, N; Satoh, K; Taima, K; Toki, T; Yamashita, K; Yoshida, H, 2007) |
| "Pretreatment with edaravone can prevent development of cognitive impairment after CEA." | 2.71 | Effects of the free radical scavenger, edaravone, on the development of postoperative cognitive impairment in patients undergoing carotid endarterectomy. ( Endo, H; Fukuda, T; Inoue, T; Kobayashi, M; Ogasawara, K; Ogawa, A; Terasaki, K; Yamadate, K; Yoshida, K, 2005) |
| "Edaravone treatment (3mg/kg, i." | 1.40 | A radical scavenger edaravone inhibits matrix metalloproteinase-9 upregulation and blood-brain barrier breakdown in a mouse model of prolonged cerebral hypoperfusion. ( Arai, K; Liang, AC; Maki, T; Miyamoto, N; Pham, LD, 2014) |
| "Cerebral ischemia was mechanically induced by 2-hour occlusion of the left middle cerebral artery (MCA) using an intraluminal filament followed by 24-hour reperfusion." | 1.33 | Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats. ( Hong, KW; Lee, JH; Lee, WS; Park, SY, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, N | 1 |
| Pham, LD | 1 |
| Maki, T | 1 |
| Liang, AC | 1 |
| Arai, K | 1 |
| Somekawa-Kondo, T | 1 |
| Yamaguchi, K | 1 |
| Ishitsuka, Y | 1 |
| Ito, S | 1 |
| Tanaka, K | 1 |
| Irikura, M | 1 |
| Moriuchi, H | 1 |
| Takahama, K | 1 |
| Ando, Y | 1 |
| Yamazaki, T | 1 |
| Irie, T | 1 |
| Lee, JH | 1 |
| Park, SY | 1 |
| Lee, WS | 1 |
| Hong, KW | 1 |
| Ogasawara, K | 1 |
| Yamadate, K | 1 |
| Kobayashi, M | 1 |
| Endo, H | 1 |
| Fukuda, T | 1 |
| Yoshida, K | 1 |
| Terasaki, K | 1 |
| Inoue, T | 1 |
| Ogawa, A | 1 |
| Ishikawa, A | 1 |
| Yoshida, H | 1 |
| Metoki, N | 1 |
| Toki, T | 1 |
| Imaizumi, T | 1 |
| Matsumiya, T | 1 |
| Yamashita, K | 1 |
| Taima, K | 1 |
| Satoh, K | 1 |
1 trial available for edaravone and Anoxia, Brain
| Article | Year |
|---|---|
Effects of the free radical scavenger, edaravone, on the development of postoperative cognitive impairment in patients undergoing carotid endarterectomy.
Topics: Aged; Antipyrine; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Cerebrovascular C | 2005 |
4 other studies available for edaravone and Anoxia, Brain
| Article | Year |
|---|---|
A radical scavenger edaravone inhibits matrix metalloproteinase-9 upregulation and blood-brain barrier breakdown in a mouse model of prolonged cerebral hypoperfusion.
Topics: Animals; Antipyrine; Blood-Brain Barrier; Carotid Artery, Common; Carotid Stenosis; Cell Death; Cell | 2014 |
Aminophylline, administered at usual doses for rodents in pharmacological studies, induces hippocampal neuronal cell injury under low tidal volume hypoxic conditions in guinea-pigs.
Topics: Aminophylline; Animals; Antipyrine; CA1 Region, Hippocampal; Creatine Kinase, BB Form; Disease Model | 2013 |
Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats.
Topics: Animals; Antioxidants; Antipyrine; Aspirin; bcl-2-Associated X Protein; Blotting, Western; Brain Ede | 2005 |
Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia.
Topics: Antipyrine; Astrocytes; Blood-Brain Barrier; Brain Edema; Cell Nucleus; Cells, Cultured; Cerebral Ar | 2007 |